Baron AD - Search Results

1

Ketoconazole retains activity in advanced prostate cancer patients with progression despite flutamide withdrawal.

Small EJ, Baron AD, Fippin L, Apodaca D. Small EJ, et al. Among authors: baron ad. J Urol. 1997 Apr;157(4):1204-7. J Urol. 1997. PMID: 9120902 Clinical Trial.

2

Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease.

Baron AD, Hollander H. Baron AD, et al. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):992-6. doi: 10.1164/ajrccm/148.4_Pt_1.992. Am Rev Respir Dis. 1993. PMID: 8214956

3

The Sweet syndrome during therapy with granulocyte colony-stimulating factor.

Park JW, Mehrotra B, Barnett BO, Baron AD, Venook AP. Park JW, et al. Among authors: baron ad. Ann Intern Med. 1992 Jun 15;116(12 Pt 1):996-8. doi: 10.7326/0003-4819-116-12-996. Ann Intern Med. 1992. PMID: 1375012 No abstract available.

4

Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.

Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD. Fineman MS, et al. Among authors: baron ad. Diabetes Care. 2003 Aug;26(8):2370-7. doi: 10.2337/diacare.26.8.2370. Diabetes Care. 2003. PMID: 12882864 Clinical Trial.

5

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD. Kolterman OG, et al. Among authors: baron ad. J Clin Endocrinol Metab. 2003 Jul;88(7):3082-9. doi: 10.1210/jc.2002-021545. J Clin Endocrinol Metab. 2003. PMID: 12843147 Clinical Trial.

6

Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes.

Henry RR, Frias JP, Walsh B, Skare S, Hemming J, Burns C, Bicsak TA, Baron A, Fineman M. Henry RR, et al. PLoS One. 2018 Sep 25;13(9):e0203946. doi: 10.1371/journal.pone.0203946. eCollection 2018. PLoS One. 2018. PMID: 30252913 Free PMC article. Clinical Trial.

7

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. DeFronzo RA, et al. Among authors: baron ad. Diabetes Care. 2005 May;28(5):1092-100. doi: 10.2337/diacare.28.5.1092. Diabetes Care. 2005. PMID: 15855572 Clinical Trial.

8

Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies.

Takiyyuddin MA, Baron AD, Cervenka JH, Barbosa JA, Neumann HP, Parmer RJ, Sullivan PA, O'Connor DT. Takiyyuddin MA, et al. Among authors: baron ad. J Clin Endocrinol Metab. 1991 Mar;72(3):616-22. doi: 10.1210/jcem-72-3-616. J Clin Endocrinol Metab. 1991. PMID: 1671783

9

Response to Bell: industry perspective.

Baron AD. Baron AD. Diabetes Care. 2001 Apr;24(4):769-70. doi: 10.2337/diacare.24.4.769. Diabetes Care. 2001. PMID: 11315845 No abstract available.

10

Ultradian variations of chromogranin A in humans.

Takiyyuddin MA, Neumann HP, Cervenka JH, Kennedy B, Dinh TQ, Ziegler MG, Baron AD, O'Connor DT. Takiyyuddin MA, et al. Among authors: baron ad. Am J Physiol. 1991 Oct;261(4 Pt 2):R939-44. doi: 10.1152/ajpregu.1991.261.4.R939. Am J Physiol. 1991. PMID: 1681748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page